Anatara Lifesciences Limited

ASX:ANR ISIN:AU000000ANR0

Anatara Lifesciences ASX ANRAnatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

     

News

Anatara Lifesciences Limited (ASX:ANR) Meet the CEO Investor Webinar

🕔9/7/2021 10:44:18 AM 1133

Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal health in humans and animals, invites shareholders to attend a virtual group briefing with Chief Executive Officer, Steven Lydeamore, on Thursday 9 September 2021 at 11:00am AEST.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Investor Presentation

🕔9/6/2021 9:36:59 AM 994

Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals, is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today to investors.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Launches IBS-D Clinical Trial Recruitment Website

🕔8/20/2021 8:13:43 AM 1962

Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to announce the launch of its IBS-D Clinical Trial recruitment website.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Successful Piglet Study

🕔8/6/2021 9:02:29 AM 1818

Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to announce the successful completion of a challenge study in weaner piglets with its recently developed bromelain-based formulation (BONIFF).

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Monthly Activities Report

🕔7/28/2021 10:29:48 AM 1589

Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 30 June 2021 (Q4 FY21), along with the Company's Appendix 4C cash flow report.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Chair Transition

🕔7/26/2021 10:14:43 AM 1831

Anatara Lifesciences (ASX:ANR), a developer of evidence-based solutions for gastrointestinal diseases in humans and animals, is pleased to announce the transition of Dr David Brookes from Non-Executive Director to Chairman.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Progressing Towards First Human Clinical Studies

🕔5/31/2021 8:41:43 AM 1603

Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals is pleased to provide this update on clinical trial activities.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Q3 FY21 Activities Report

🕔4/27/2021 8:34:50 AM 1817

Anatara Lifesciences (ASX:ANR), a developer of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 31 March 2021, along with the Company's Appendix 4C cash flow report.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Ethics Approve Adult Psychological Functioning Trial start

🕔4/20/2021 8:27:47 AM 1946

Anatara Lifesciences (ASX:ANR) is pleased to advise that it is has received Human Research Ethics Committee (HREC) approval to undertake a clinical trial on the effects of 3FDC dietary supplementation on psychological functioning in an adult population.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Announces Australian Patent Grant for Detach

🕔4/16/2021 9:15:44 AM 2182

Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce the grant of patent number AU2019204496 entitled "Anti-diarrhea formulation which avoids antimicrobial resistance".

Read Full Article
###

73,992 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 222) (Last 30 Days: 1444) (Since Published: 73992) 

Company Data

    Headquarters
  • Level 3, 62 Lygon Street
    Carlton South, VIC, 3053
    Australia
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.anataralifesciences.com
  • E:
  • info@anataralifesciences.com

Company Reports